Blood Test May Detect Pancreatic Cancer Earlier, Allow for ‘Meaningful Intervention’
Scientists report the PANXEON blood test detects early-stage pancreatic cancers about 87% of the time, potentially enabling earlier intervention for a deadly disease.
8 Articles
8 Articles
The liquid biopsy called PANXEON, which was presented in the context of international research, appears to have high sensitivity in detecting pancreatic cancer and precancerous lesions The post Pancreatic cancer: New blood test gives hope for early detection appeared first on in.gr.
The new method tested on 1,800 patients in the US, Europe and Asia uses biomarkers and AI to detect malignancy and precancerous lesions
Blood test may detect pancreatic cancer earlier, allow for ‘meaningful intervention’
An investigational blood test may allow for detection of pancreatic cancer at its earliest stages when it is potentially curable, according to prospective study results.The liquid biopsy also demonstrated the ability to identify high-grade dysplasia in the pancreas. Detection of the precancerous condition could establish a window for treatment prior to the development of invasive disease,
The test detected pancreatic cancer at stages 1 and 2 in 87% of cases, while also detecting precancerous lesions in over 64%.
The news about pancreatic cancer is encouraging, according to an international study, if it is detected at an early stage. A new blood test that will ... The article Pancreatic Cancer: The Blood Test That Can Detect It at an Early Stage was published in NewsIT.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
